Port Erin Biopharma Investments Ltd Stock price London S.E.
Equities
IM00B6QH1J21
Investment Management & Fund Operators
Sales 2022 | 6.42M 8.11M | Sales 2023 | 29.7M 37.48M | Capitalization | 104M 131M |
---|---|---|---|---|---|
Net income 2022 | 8M 10.09M | Net income 2023 | 22M 27.76M | EV / Sales 2022 | 1.58 x |
Net cash position 2022 | 146M 185M | Net cash position 2023 | 170M 214M | EV / Sales 2023 | -2.23 x |
P/E ratio 2022 |
17.6
x | P/E ratio 2023 |
4.73
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 82.21% |
Managers | Title | Age | Since |
---|---|---|---|
Denham Eke
DFI | Director of Finance/CFO | 73 | 12-05-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Mellon
FOU | Founder | 68 | 11-05-02 |
Richard Reed
BRD | Director/Board Member | 51 | 19-05-30 |
David Giampaolo
BRD | Director/Board Member | 65 | 19-05-30 |
1st Jan change | Capi. | |
---|---|---|
+31.41% | 12.02B | |
+10.68% | 2.89B | |
+6.02% | 1.49B | |
-8.46% | 1.2B | |
-2.74% | 592M | |
-14.77% | 562M | |
+41.30% | 525M | |
+22.99% | 524M | |
-1.32% | 474M |